May 14, 2026
Senores Pharmaceuticals Q4 FY26: Revenue up to ₹175.19 crore
Senores Pharmaceuticals Limited — Quarter and year ended March 31, 2026 Optional commentary: Extracted financial tables from the provided quarterly results document (Annexure-A and standalone/consolidated statements)....
